328 results on '"Moreaux, Jerome"'
Search Results
2. Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation
3. An atlas of cells in the human tonsil
4. PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma
5. The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5
6. G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
7. Immunotherapy perspectives in the new era of B-cell editing
8. KDM6A controls immunogenicity in MM
9. EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
10. Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features
11. Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features
12. DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
13. Supplementary Table S1 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
14. Supplementary Data from Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
15. Supplementary Figure from Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
16. Supplementary Table from Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
17. Supplementary Figure S3 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
18. Editorial: Transcriptional control in normal and malignant B-lymphocytes
19. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma
20. Analysis of Global Gene Expression Profiles
21. Growth Factors in Multiple Myeloma
22. Targeting the β 2 ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
23. Development of a Robust BH3 Profiling Toolkit for Precision Medicine in Hematologic Malignancies
24. Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma
25. EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma
26. Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction
27. PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
28. Single-hit genome edition for expression of single-chain immunoglobulins by edited B cells
29. Clinical and prognostic role of annexin A2 in multiple myeloma
30. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells
31. Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
32. Pivotal role of PIM2 kinase in plasmablast generation and plasma cell survival, opening new treatment options in myeloma
33. Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration
34. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
35. Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
36. Exploiting Transcription-Replication Conflicts As a Novel Therapeutic Intervention in Multiple Myeloma
37. Preliminary Study of Ruxolitinib and Venetoclax for Treatment of Patients with T-Cell Prolymphocytic Leukemia Refractory to, or Ineligible for Alemtuzumab
38. Genomic Characterization of in Vitro Acquired-Resistance to Proteasome Inhibitors
39. Induction of angiogenesis by normal and malignant plasma cells
40. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
41. Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma
42. Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types
43. Discovery of Candidate DNA Methylation Cancer Driver Genes
44. Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression
45. Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology
46. Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications
47. Lipid-Mediated Modulation of DNA Damage Signaling As a Prognostic and Therapeutic Strategy Against Multiple Myeloma
48. Characterization of a New Metabolic Score Correlated with CD38 Cell-Surface Expression and Response to Daratumumab Treatment in Multiple Myeloma
49. Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy
50. Integrative Single-Cell RNA-Seq and Single-Cell ATAC-Seq Analysis of Human Plasma Cell Differentiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.